Showing results (11-20 of 176) with videos related to
Sort By:
Pageof 18
Blood|October 4, 2016
Hedgehog pathway activation in T-cell acute lymphoblastic leukemia predicts response to SMO and GLI1 inhibitorsAntonis Dagklis, Sofie Demeyer, Jolien De Bie, et al.Blood|December 1, 2017
Mutant JAK3 signaling is increased by loss of wild-type JAK3 or by acquisition of secondary JAK3 mutations in T-ALLSandrine Degryse, Simon Bornschein, Charles E de Bock, et al.Chemistry & Biology|March 29, 2011
JAK3 specific kinase inhibitors: when specificity is not enoughLuk Cox, Jan CoolsBlood Cancer Discovery|October 18, 2021
Genomics, Transcriptomics, and Minimal Residual Disease Detection: The Winning Team to Guide Treatment of Acute Lymphoblastic LeukemiaHeidi Segers, Jan CoolsPharmaceuticals (Basel, Switzerland)|June 2, 2021
Deregulation of the Interleukin-7 Signaling Pathway in Lymphoid MalignanciesInge Lodewijckx, Jan CoolsExpert Review of Anticancer Therapy|September 19, 2009
Recent breakthroughs in the understanding and management of chronic eosinophilic leukemiaEls Lierman, Jan CoolsNature Genetics|October 29, 2015
The genomic landscape of adult T cell leukemia/lymphomaCarmen Vicente, Jan CoolsJournal of Hematology & Oncology|July 26, 2015
JAK kinase inhibitors for the treatment of acute lymphoblastic leukemiaSandrine Degryse, Jan CoolsBlood|September 8, 2019
Suz12 inactivation cooperates with JAK3 mutant signaling in the development of T-cell acute lymphoblastic leukemiaMichael Broux, Cristina Prieto, Sofie Demeyer, et al.Blood|September 7, 2014
JAK3 mutants transform hematopoietic cells through JAK1 activation, causing T-cell acute lymphoblastic leukemia in a mouse modelSandrine Degryse, Charles E de Bock, Luk Cox, et al.Pageof 18